What's Hot
View all perspectives
Robert B Chao, MD doctorRBC
4 years ago
NT-proBNP and TnI predicted cardiovascular events in patients with PsO or PsA. Abs#1328
Do you measure/monitor for cardiovascular disease in your psoriatic patients?
@RheumNow #ACR20
Dr. Antoni Chan synovialjoints
4 years ago
In patients with Crohn's disease (CD), the presence of HLA-B27 and higher clinical activity of CD were associated with presence of SpA. SpA was present in 21% of early CD patients @RheumNow #ACR20 Abstr#1308
Meral K. El Ramahi, MD MeralElRamahiMD
4 years ago
Do you recommend Omega-3 fish oil (2-9 grams per day) to your patients with RA (doubled blinded RCT in 140 pts w/ recent onset of RA showed increased likelihood of achieving remission & less failure of triple therapy in high-dose fish oil group). #ACR20 @RheumNow @LCalabreseDO
Dr. Rachel Tate uptoTate
4 years ago
UPA was efficacious in treating axial symptoms in pts with PsA. #ABS1372 #ACR20 @RheumNow https://t.co/ut6L0jM9WJ https://t.co/6H2N3ap6eI
sheila RHEUMarampa
4 years ago
This study shows that serum anti-PAD4, anti-PAD3/4XR abs are highly specific for RA-ILD and assoc'd w/ better lung function in RA-UIP.
Small patient sample. Potential prognostic biomarker? @RheumNow #ACR20 abs1200 https://t.co/f5VFjJhVXF
Dr. John Cush RheumNow
4 years ago
Patients with hyperCKemia (Sxs or not) and positive myositis Abs are more likely to have a positive Muscle Bx and Dx of inflammatory myositis - Single center study. #ACR20 Abstr#1074 https://t.co/vnsxmPTuPu https://t.co/qEseldIQ7x
David Liew drdavidliew
4 years ago
Biosimilars are not just about savings.
More manufacturers can mean innovation:
better programs/devices
pursuing new indications eg COVID
sc formulations
CT-P13 infliximab biosimilar: immunogenicity sc vs iv same.
Particularly useful in pandemic times!
#ACR20 ABST1208 @RheumNow https://t.co/WjJ6OOST55
k dao KDAO2011
4 years ago
#ACR20 Dr. M. Crow on Lupus #StateofArtLecture
ANA prevalence is increasing over time-- unclear why. @RheumNow https://t.co/BMTzxuhvLh
Dr. Rachel Tate uptoTate
4 years ago
SELECT-PsA1 results UPA showed improvements in PROs vs PBO at 12 weeks in biologic DMARD-naïve patients w/ active PsA, which were maintained or further improved at Week 24. #ABS1341 #ACR20 @RheumNow https://t.co/q5tYItFb6g https://t.co/4QilMDBaXc
Mrinalini Dey DrMiniDey
4 years ago
Analysis across the lifecourse shows early exposure to passive #smoking is associated with incident seropositive #rheumatoidarthritis in adulthood- results from @kaz_yos and colleagues.
Abs#1000 #ACR20 @RheumNow
https://t.co/MboLBGk9yv
Janet Pope Janetbirdope
4 years ago
Will you use belimumab in lupus nephritis? Abstr#1441 @RheumNow @CRASCRRheum #ACR20
Eric Dein ejdein1
4 years ago
Another great thieves market imaging - whole body pain after starting antifungal? Check out TM17 for diagnosis! #acr20 @RheumNow https://t.co/8VIGi7mbMY
Meral K. El Ramahi, MD MeralElRamahiMD
4 years ago
Unilateral hip pain in a 27 yo male w/ hx of dermatomyositis on IVIG, MMF, & GC. MRI image below. What’s your diagnosis? Biopsy or no biopsy? Check out Thieves Market poster 19 by Dr. Son from @jhrheumatology. #ACR20 @RheumNow https://t.co/g9R1bB4LeS
Richard Conway RichardPAConway
4 years ago
Dr @Juge_P_A @PhilippeDieude in abstr#1195 present that MUC5B promoter variant not associated with disease progression or need for transplant in RA-ILD. Interesting, as it is associated with both RA-ILD and IPF, and with a better prognosis in IPF #ACR20
@rheumnow https://t.co/2Kdpq73AIP
Richard Conway RichardPAConway
4 years ago
Dr @Juge_P_A @PhilippeDieude on potential role for MUC5B genotyping in risk stratification for RA-ILD. Makes sense but need to clarify exact role. Abst#1194 #ACR20 @rheumnow https://t.co/crLfz2duWF
Poster Hall